Our company was founded by John Fisher MD, an interventional radiologist with extensive
experience in breast imaging and breast biopsy. He has performed over 500 stereotactic
and ultrasound guided breast biopsies, and breast biopsy site marker placements. His experience,
combined with his ground-breaking ideas, has brought innovative products to the world of medicine.
Dr. Fisher was an early adopter of the vacuum assisted breast biopsy and was selected as an
instructor to work alongside Steve Parker MD, a pioneer for developing and promoting vacuum
assisted breast biopsy procedures. Dr. Fisher instructed courses at RSNA on how to
perform vacuum assisted stereotactic guided Mammotome breast biopsy procedures.
The HydroMARK was developed by Dr. Fisher and his team to meet an unmet clinical need. The HydroMARK
is a novel, water containing, ultrasound visible marker. This new product has helped his patients
by replacing lengthy mammogram guided wire localization procedures with quick,
accurate ultrasound guided localization procedures that are more comfortable.
Biopsy Sciences has also developed the BioSEAL biopsy tract sealant which significantly
reduces the incidence of pneumothorax and chest
tube placement following CT guided lung biopsy. The BioSEAL was acquired by Angiotech
Pharmaceuticals in 2008.